USER GUIDE
SAMPLE QUERY SCREEN

SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS
 

 NOTE ON COMBINATION TRIALS

 

The Combination Trials module currently contains only trials using combinations of approved chemotherapeutics and/or other approved treatment modalities. Descriptions include protocols and/or interim results of ongoing trials and final results of completed trials. The database only reports information from published trials.

Clinical trials using novel agents in combination with other novel agents or approved drugs/modalities are described in the New Drugs module. In order to see trials using commercial agents in combination with novel drugs, enter the name of the commercially available drug, i.e. cisplatin, in the Clinical History field of the New Drug query screen and submit the query. To find the description of trial(s) involving the desired drug (cisplatin), call up each individual drug record and use your browser find function (Ctrl-F) to navigate to the desired description.

To search, type words or phrases in the boxes, then click either of the SUBMIT QUERY buttons on the page. In the search boxes, use the following characters to broaden or narrow your search:

  • Wildcard Search - Use a * to include all word endings (bio*).
  • AND - Use an & between terms to indicate that both words must be present (leukemia & lymphoma).
  • OR - Use a / between terms to indicate that either word can be present (leukemia / lymphoma).
  • NOT - Use an ! between terms to exclude words from the search (leukemia ! myelocytic).

When searching multiple fields, click on the AND drop down box to change to OR or NOT if needed.

If unsure of what to type in a given field, click on the field name to see the help screen for that field. To browse possible entries click on the browse buttons.

Select Report Format:

SUMMARY TABLE
BIOMARKER/TARGET TABLE

Keywords

Search Guide

Drug

Modality

Institution

Clinical Trial
Title/Objective

Cancer Indication

Clinical Indication

Clinical Status

Enrollment

Target

Toxicity

Protocol

Administration Route
Administration Route Details

Biomarkers

Reference

Current as of

SEARCH TRIAL RESULTS

Result Summary

Complete Response (CR)

Partial Response (PR)

Stable Disease (SD)

Overall Response (OR)

Clinical Benefit Rate (CBR)

Median Survival Time (MST)

Overall Survival (OS)

Median Time to Progresson (TTP)

Progression Free Survival (PFS)

1-year Survival

Search Guide

Drug
Modality
Institution
Clinical Trial
Cancer Indication
Clinical Indication
Clinical Status
Enrollment
Target
Toxicity
Protocol
Reference
Current as of
SEARCH TRIAL RESULTS
Result Summary
Complete Response (CR)
Partial Response (PR)
Stable Disease (SD)
Overall Response (OR)
Median Survival Time (MST)
Overall Survival (OS)
Median Time to Progresson (TTP)
Progression Free Survival (PFS)
1-year Survival

Search Guide

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM